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Abstract  
Our aim was to shed light on different steps leading from metabotropic receptor activation to changes in cell 
shape, such as those that characterize the morphological plasticity of neurohypophysial astrocytes (pituicytes). 
Using explant cultures of adult rat pituicytes, we have previously established that adenosine A1 receptor 
activation induces stellation via inhibition of RhoA monomeric GTPase and subsequent disruption of actin stress 
fibers. Here, we rule out RhoA phosphorylation as a mechanism for that inhibition. Rather, our results are more 
consistent with involvement of a GTPase-activating protein (GAP). siRNA and pull-down experiments suggest 
that a step downstream of RhoA might involve Cdc42, another GTPase of the Rho family. However, RhoA 
activation, e.g., in the presence of serum, induces stress fibers, whereas direct Cdc42 activation appears to 
confine actin within a submembrane—i.e., cortical—network, which also prevents stellation. Therefore, we 
propose that RhoA may activate Cdc42 in parallel with an effector, such as p160Rho-kinase, that induces and 
maintains actin stress fibers in a dominant fashion. Racl is not involved in the stellation process per se but 
appears to induce a dendritogenic effect. Ultimately, it may be stated that pituicyte stellation is inducible upon 
mere actin depolymerization, and preventable upon actin organization, be it in the form of stress fibers or in a 
cortical configuration. 
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Introduction 
In recent years, considerable attention has been given to the morphofunctional plasticity of glial cells as an 
important means of maintaining homeostasis in the nervous system. The hypothalamus-neurohypophysis system 
represents an example where such a plasticity may have direct physiological significance. For instance, during 
relevant stimulations, such as dehydration or lactation, astrocytes of the posterior pituitary (pituicytes) retract 
from perivascular spaces, thereby increasing access of secreting terminals to the basal lamina, and facilitating 
release of vasopressin (VP) or oxytocin into the blood (reviewed in Theodosis and MacVicar 1996; Hatton 
1999). 
Our previous in vitro studies showed that the morphological plasticity of pituicytes can be controlled via specific 
membrane receptors of the G-protein-coupled receptor (GPCR) family, and downstream regulation of RhoA and 
Cdc42 GTPase activity (Rosso et al. 2002a, b). In culture conditions, pituicytes exhibit a flat, spread shape due to 
serum components (e.g., lysophosphatidic acid; LPA) that are powerful RhoA activators (Ramakers and 
Moolenaar 1998). Spreading is maintained in serum concentrations as low as 0.025%, a condition that in turn 
allows induction of stellation by adenosine Al receptor activation and reversible inhibition of RhoA. Stellation 
can also be induced by C3 toxin, an irreversible RhoA inhibitor, and by Y-27632, an inhibitor of the RhoA 
effector pl60Rho-kinase. Stellation induced by adenosine, C3 toxin or Y-27632 can be reversed—i.e., spreading 
can be restored—by subnanomolar concentrations of the neurohormone VP acting at V1a receptors. These 
findings have physiological relevance because (1) adenosine is readily generated from breakdown of ATP, which 
is present in VP secretory vesicles (Gratzl et al. 1980), (2) exocytosis of these vesicles occurs locally from axon 
swellings, i.e. in the pituicyte environment (Morris et al. 1988), and (3) pituicyte shape in turn is likely to 
influence neurohormone output (Theodosis and MacVicar 1996; Hatton 1999). 
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The fact that VP reverses stellation induced by the irreversible RhoA inhibitor C3 argued against a RhoA-
dependent effect of the hormone. Indeed, our pull-down assays showed no increase of activated RhoA in the 
presence of VP. Instead, consistent with our previous observation that VP induces the formation of short 
membrane protrusions resembling filopodia, a process known to be under the control of Cdc42 (Hall 1998), we 
have found that VP reverses stellation through Cdc42 activation. Thus, in pull-down assays VP increases the 
amount of activated Cdc42, and VP-mediated reversal of stellation is blocked by transfection of NWASP-GBD, 
the GTPase binding domain of a Wiscott-Aldrich syndrome-related protein that blocks endogenous Cdc42 
(Rosso et al. 2002b). As RhoA inhibition alone is sufficient to induce stellation, our initial hypothesis was that in 
"resting" conditions (e.g., 0.025% serum) Cdc42 is inactive, or at least is not active enough to induce spreading. 
However, another possible interpretation is that RhoA and Cdc42 are functionally linked. For instance, it has 
been suggested that RhoA can act downstream of Cdc42 (Hall 1998). This scheme, nevertheless, is highly 
unlikely in pituicytes as Cdc42 activation by VP (1) reverses C3-induced stellation (whereas LPA fails to do so), 
and (2) does not change the level of activated RhoA as measured in pulldown assays (whereas LPA does). The 
converse possibility that RhoA may activate Cdc42 was not examined in our previous work. Here, we used 
small-interfering (si) RNA and mutant GTPase expression techniques in order to expand our understanding of 
the respective roles of RhoA and Cdc42 in pituicyte shape changes. Additional objectives were (i) to gain further 
insight into the mechanism of RhoA inhibition by adenosine; (ii) to investigate any potential role of Rac1, 
another monomeric GTPase involved in cell morphology; and ultimately (iii) to identify the cytoskeletal targets 
that transduce the observed plasticity of pituicytes. 
Materials and Methods 
Pituicyte Cultures and Morphological Analysis 
Pituicyte explant cultures were prepared as described previously (Rosso et al. 2002a) from adult Wistar rats 
(150-200 g) anesthetized with pentobarbital (55 µg g-1) and decapitated in accordance with French/European 
ethical guidelines. We used 8-12-day-old cultures plated on collagen-coated Petri dishes. Due to the inhibitory 
effect of serum on stellation, cells were switched to a low-serum (0.025%) medium one hour prior to 
experiments, a standard procedure followed by most authors (e.g., Ramsell and Cobbett 1997; Abe and Saito 
1998). All drugs or their vehicle as control were added one hour (37°C) prior to phase-contrast image 
acquisition. The latter was performed with a digital still camera and Adobe Photoshop software was used for cell 
counting. Digitized images were coded with respect to treatment in order to perform blind counting. Cells were 
considered as stellate when they displayed phase-bright somas with two or more processes at least 2 soma 
diameters long (Narumi et al. 1978). For each culture dish, relative stellation (number of stellate/total cells in 
field × 100) was assessed by counting 100-200 cells at 10× magnification over 5 arbitrarily chosen areas 0.9 × 
0.7 mm wide, and taking the resulting average. 
siRNA Transfection 
RhoA and Cdc42 siRNAs (for sequences see Deroanne et al. 2005, the "first" siCdc42 sequence was used in the 
present study) were purchased from Eurogentec (Seraing, Belgium) and transfected into cells grown in regular 
(10%) serum medium using a Ca2+ phosphate protocol as described previously (Vouret-Craviari et al. 2004). 
Cells were analyzed 48 h after the second transfection. The efficiency of protein silencing was assessed by 
western blot using specific antibodies obtained from Santa Cruz Biotechnology (mouse anti-RhoA), 
Transduction Laboratories (mouse anti-Cdc42), or Sigma (mouse anti-α smooth muscle actin). Blots were 
analyzed with Scionlmage software to perform light intensity quantification over bands of interest. Relative light 
intensity was then normalized and is expressed as the ratio of GTPase signal intensity divided by corresponding 
actin signal intensity. 
DNA Constructs 
RhoA-S188A and S188D (see supplemental data in Rolli-Derkinderen et al. 2005, for primers used in 
mutagenesis), cloned in the pKH3-HA vector, were provided to us by G. Loirand (INSERM U533, Nantes, 
France). RhoA-G14V, cloned in the pSG5 vector, was given to us by P. Chardin (CNRS UMR 6097, Nice, 
France). The GFP fusion proteins of Cdc42-V12 and Rac1, cloned in the pEGFP-C1 vector (Roux et al. 1997; 
Gadea et al. 2002), were provided by P. Roux (CNRS FRE 2593, Montpellier, France). 
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Transfection, Retroviral Infection and Fluorescence Labeling 
In order to monitor the morphological effects of RhoA mutants, we used a modified version of the GFP reporter 
method (Fincham et al. 1999); using the Ca2+ phosphate method, pituicytes were transfected with either GFP 
alone (pEGFP plasmid, Clontech) as control or cotransfected with GFP and RhoA mutants at a 1:10 
concentration ratio. Regarding Cdc42 and Racl experiments, we have transduced pituicytes as follows: retroviral 
packaging HEK-293 Phoenix cells were transfected using a modified Ca2+ phosphate protocol in the presence of 
25 mM chloroquine. The next day, the medium was replaced with fresh growth medium. After 48 h, conditioned 
medium was harvested, filtered through a 0.45-µm filter, and polybrene was added to a final concentration of 4 
µg/ ml. For infection, pituicytes were trypsinized 4 h before the addition of the viral supernatant. After exposure 
to specific control and test conditions as indicated, the cells were fixed with 3% paraformaldehyde +2% sucrose 
at 37°C, washed 3 times in PBS, permeabilized for 4 min in PBS +0.2% Triton, and again rinsed 3 times in PBS 
and saturated 15 min in PBS +5% serum. Actin was labeled with rhodamine- or fluorescein-conjugated 
phalloidin. Pituicytes transfected or transduced with the different vectors and/ or labeled with phalloidin were 
mounted on slides in the presence of Citifluor for observation on an epifluorescence microscope at appropriate 
wavelengths. 
Cdc42 Activity Assay 
Pull-down assays were performed using bacterially produced GST-CRIB (Cdc42/Rac interactive binding domain 
from PAK) as described previously (Rosso et al. 2002a, b) on five 60-mm culture dishes per experimental 
condition (see details in Results). Levels of activated and total Cdc42 were determined by Western blotting 
(monoclonal anti-Cdc42 # C70820, Transduction Laboratories) and used to quantify GTPase activation by 
densitometric analysis. The optical density of each band on the blot was analyzed with PCBAS software 
(Raytest, Straubenhardt, Germany) and, after background subtraction, the ratio of activated/total GTPase was 
calculated. 
Drugs 
Adenosine, phalloidin-TRITC or FITC, cytochalasin D, calyculin-A, and vasopressin were purchased from 
Sigma. Jasplakinolide was from Calbiochem. 
Results 
Effects of Monomeric GTPase Expression on Pituicyte Morphology 
In order to gain insight into the role of RhoA and Cdc42 in pituicyte morphology, we used a loss of function 
approach to silence expression of each protein. Transfection of pituicytes with RhoA or Cdc42 siRNA duplexes 
resulted in a substantial decrease (~70 or 80% respectively), but not complete disappearance of protein 
expression (Fig. 1). Transfected cells were analyzed for their morphological features, which revealed a moderate 
tendency for stellation in both RhoA- and Cdc42-depleted cells, as compared to control cells (Fig. 2). The key 
finding of these experiments is that Cdc42 silencing results in significant stellation indicating, contrary to our 
initial assumption, that the GTPase is somewhat active in basal conditions. This in turn suggests a functional link 
between RhoA and Cdc42, given the fact that RhoA inhibition per se induces stellation. As mentioned earlier, a 
control of Cdc42 over RhoA is highly unlikely; thus, we here tested the alternative possibility that Cdc42 acts 
downstream of RhoA. For that purpose, we performed a Cdc42 pull-down in conditions of RhoA inhibition by 
10 µM adenosine versus its full activation by 10% serum (see Rosso et al. 2002a). For comparison, we included 
Cdc42 activity measurements during 5 or 10-min exposures to 10 nM VP, which we previously showed to be a 
reliable Cdc42 activator (Rosso et al. 2002b). The results indicate that Cdc42 activity in serum is comparable to 
that obtained with VP, and higher than that in the presence of adenosine (Fig. 3), i.e. in conditions of RhoA 
inhibition. Although we cannot exclude the possibility of a direct effect of serum on Cdc42, an interpretation 





Published in : Cellular & Molecular Neurobiology (2007) 
Status : Postprint (Author’s version) 
 
Fig. 1 Western blots of RhoA and Cdc42 protein expression in pituicytes transfected with siRNAs targeting 
either protein. Left panels show sample gels in which upper bands in left lanes correspond to a control signal 
obtained for each GTPase from cells transfected with siRNA targeting the other GTPase, while right lanes show 
the signal obtained from cells transfected with siRNA targeting the same GTPase. Lower bands correspond to 
actin detected in samples and used for normalizing the amounts of RhoA or Cdc42. Right panels summarize 
relative intensity of protein signal obtained from cells with or without transfection of siRNA targeting the 




Fig. 2 Effects of RhoA or Cdc42 siRNA transfection on pituicyte morphology. Phase-contrast microphotographs 
show pituicyte cultures under each relevant condition as indicated. Scale bar = 40 µm. Lower right panel 
summarizes relative stellation quantified in each condition, *p = 0.02 (n = 11); #p = 0.01 (n = 22) compared to 
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Fig. 3 Pull-down of Cdc42 in various conditions as indicated. Upper panels show western blots of total and 
activated protein from pituicytes incubated in 0.025% serum with 10 µM adenosine (Ado) for 45 min, to which 
10 nM VP was added for 5 or 10 min, or in 10% serum (no drug added). Lower panel shows the corresponding 
ratio of activated/total Cdc42 
 
 
Fig. 4 Effects of constitutively active RhoA mutant (G14V) transfection on pituicyte morphology. Upper panels 
correspond to control conditions (GFP alone, no G14V). Based on a 1:10 concentration ratio cotransfection of 
GFP + mutant, bright cells in lower panels presumably reflect successful transfection of the mutant. Left: 
without adenosine; right: with 10 µM adenosine (ado). Notice two dim cells in lower right panel (arrowheads) 
that presumably fail to express G14V and therefore appear stellate. Scale bar: 50 µm 
 
 
In order to confirm the major role of RhoA in pituicyte stellation and gain further insight into the mechanism 
involved, we transfected cells with GFP either alone or in combination with RhoA-G14V, a constitutively active 
mutant of the GTPase. GFP transfection did not induce any effect in pituicytes, which maintained their spread 
shape in control conditions, and became stellate in the presence of 10 µM adenosine (Fig. 4, upper panels). This 
rules out non-specific effects of the transfection procedure on pituicyte morphology. Likewise, cotransfection of 
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GFP + RhoA-G14V did not affect spread pituicytes (Fig. 4, lower left panel). On the other hand, RhoA-G14V 
expression clearly prevented adenosine from inducing pituicyte stellation (Fig. 4, lower right panel), consistent 
with our previous finding that adenosine induces stellation via RhoA inhibition. In order to determine whether 
the mechanism of inhibition involves serine phosphorylation of RhoA, as was shown in other cell types (Lang et 
al. 1996; Ellerbroek et al. 2003), we transfected pituicytes with two types of mutants: RhoA-S188A, a 
phosphorylation-resistant mutant, or RhoA-S188D, a phosphomimetic mutant. The former had no effect on 
spread pituicytes nor did it prevent adenosine from inducing stellation, whereas the latter mutant by itself did not 
induce stellation (Fig. 5). This suggests that adenosine induces pituicyte stellation by inhibiting RhoA via a 
mechanism other than phosphorylation. 
We then investigated in more detail the role of Cdc42 in pituicyte morphology. For that purpose, we transduced 
cells with Cdc42-V12, a constitutively active mutant of the GTPase, fused to GFP. The expression of GFP alone 
did not prevent adenosine from inducing stellation, which is characterized by a diffuse staining of actin in both 
transfected and non-transfected cells (Fig. 6, upper panels). Conversely, cells expressing Cdc42-V12 were 
resistant to adenosine-induced stellation, with actin rather organized as a submembrane—i.e., cortical—structure, 
despite the sparse presence of stress fibers (Fig. 6, lower panels). A more complete depiction of this phenomenon 
is presented in Fig. 7, in which control pituicytes display a dense alignment of stress fibers in resting conditions 
(i.e. with RhoA activated) versus a diffuse distribution of depolymerizing actin in the presence of adenosine 
(upper panels). Conversely, the actin of pituicytes expressing Cdc42-V12 retains a cortical localization following 
addition of adenosine(lower panels). As expected, adenosine-mediated stellation is prevented solely in those 
cells that express the Cdc42 mutant (lower right panel). Note that cortical actin also prevails a short time after 
exposure of stellate wild-type pituicytes to VP (inset), which has been shown to activate Cdc42 (Rosso et al. 
2002b). 
As Rac1 is known to be implicated in cell morphology (Hall 1998), we investigated its potential role in pituicyte 
stellation using constitutively active (V12) or dominant negative (N17) mutants of the GTPase. Neither V12- nor 
N17-Rac1 transduction had any effect on either "resting" pituicytes, which remained spread, or adenosine-
stimulated cells, which became stellate in the presence of the purine (Fig. 8). On the other hand, a consistent 
finding was that adenosine-stimulated, stellate pituicytes expressing Rac1-V12 are larger and exhibit more 
numerous, long and branched processes than control cells (Fig. 8, top panel). 
 
Fig. 5 Effects of phosphorylation-resistant (S188A) or phosphomimetic (S188D) RhoA mutant transfection (same 
method as in Fig. 4) on pituicyte morphology. Left image: S188A alone; middle image: S188A + 10 µM 
adenosine; note that not all cells are stellate consistent with the fact that adenosine never induces 100% 
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Fig. 6 Effects of expression of a V12 constitutively active mutant of Cdc42 on adenosine-mediated pituicyte 
stellation. All pictures are in the presence of 10 µM adenosine. Actin is labeled with rhodamine-conjugated 
phalloidin (red). Upper row shows cells expressing GFP (green) alone (no V12); lower row shows cells 




Fig. 7 Effects of Cdc42 activation on pituicyte actin cytoskeleton. Upper two pictures and inset represent wild-
type pituicytes in 0.025%-serum medium, which maintains basal RhoA activation and dense actin (red) stress 
fibers in control conditions, and allows stellation in the presence of 10 µM adenosine. Inset displays initiation of 
stellation reversal by 10 nM VP applied for 3 min. Lower pictures are overlays of actin (red) and GFP+Cdc42-
V12 (green) fluorescence. Left image: two V12+ cells (center) have lost most of their stress fibers and instead 
display cortical actin. Right image: V12-negative cells (arrowheads) are stellate in the presence of 10 µM 
adenosine, while V12+ cells are not. Notice the even more pronounced cortical localization of actin (yellow 
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Fig. 8 Effects of Rac1 constitutively active (V12) or dominant negative (N17) mutant expression on pituicyte 
morphology. Top panels show pituicytes expressing (GFP fluorescence) Rac1-V12 or Rac1-N17 in the presence 
of 10 µM adenosine. Scale bar: 40 µm. Bottom graph summarizes stellation observed in cells expressing Rac1-
V12 or Rac1-N17 in the presence or absence of 10 µM adenosine (n = 3 dishes for each condition; only GFP+ 
cells were counted) 
 
Pituicyte Stellation and the Actin Cytoskeleton 
Given the fact that RhoA or Cdc42 activation appears to block stellation in association with specific states of 
actin polymerization, we hypothesized that actin depolymerization might be a sufficient factor for pituicyte 
stellation. Similar to a previous study using cytochalasin B (Miyata et al. 1999), we found that actin 
depolymerization by cytochalasin D indeed was a powerful means of inducing pituicyte stellation, with results 
consistently near 100% efficiency (Fig. 9, lower left panel). Conversely, pituicyte incubation with increasing 
concentrations of jasplakinolide (JPK), a cell-permeant drug that stabilizes F-actin, provided proportionally 
increasing, i.e., dose-dependent, resistance to adenosine-mediated stellation up to almost complete blockade (Fig. 
9). At high concentrations (1-5 µM), JPK induced shape changes somehow resembling stellation, though treated 
cultures consisted more of both net-like structures with shriveling, dark somas and rounded, phase-bright but 
processless cells. As these effects might be nonspecific, they were not further investigated. 
Next, to test whether cortical actin organization was a sufficient condition to prevent stellation, we treated 
pituicytes with calyculin-A, a phosphatase inhibitor that dissolves stress fibers and induces cortical actin 
redistribution (Kreienbühl et al. 1992; Patterson et al. 1999). A striking result of that treatment was the rounding 
up of pituicytes along with a tendency to form aggregates, an effect consistently observed in various cell types 
(e.g. Patterson et al. 1999). It is unlikely that cell rounding was the result of a non-specific, toxic effect of 
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calyculin-A since (1) we used a concentration ~20 times lower than that used in most studies, and (2) we did not 
observe any tendency of treated cells to detach from substrate. Following addition of adenosine, pituicytes 
remained rounded but no processes were formed, i.e., stellation was inhibited by calyculin-A (Fig. 9, upper right 
panel). Finally, we verified that the actin cytoskeleton of JPK- or calyculin-A-treated cells was as predicted. 
Figure 10 shows that pituicytes incubated with 250 nM JPK or 5 nM calyculin-A display an actin cytoskeleton 
organized respectively as a stress-fiber or cortical network, both before and after addition of 10 µM adenosine. 
 
Fig. 9 Effects of cytoskeleton-targeting drugs on pituicyte stellation. Phase-contrast pictures of pituicyte cultures 
in 0.025%-serum medium were taken in the various conditions indicated. Control image corresponds to no drug 
added (first zero on graph). Jasplakinolide (JPK) or calyculin-A were added 45 min before adenosine. 
Treatment with 10 µM cytochalasin-D induced 93 ± 2% stellation (n = 5), while 5 nM calyculin-A resulted in 
virtually 0% stellation (n = 6). Scale bar: 70 µm. Bottom right: Concentration-dependent inhibition of 10 µM 
adenosine-induced pituicyte stellation by JPK (n = 3 or 4 dishes per condition). Adenosine was present as 
indicated by the bar above the graph 
 
 
Fig. 10  Effects of jasplakinolide (JPK) or calyculin-A on pituicyte actin cytoskeleton. Note the same patterns of 
phalloidin labeling before or after addition of 10 µM adenosine. Scale bar = 50 µm 
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Discussion 
Our siRNA experiments resulted in significant yet incomplete inhibition of RhoA and Cdc42. This is shown by 
the results of both our western blot and morphological analyses. In particular, if RhoA silencing was equivalent 
to its pharmacological inhibition, we would have expected a much higher level of stellation, which generally 
averages 70-80% in the presence of adenosine (e.g., Figs. 8 and 9). In addition to incomplete silencing, the fact 
that our knock-downs were performed in 10% serum suggests that remaining RhoA was in a fully activated 
form, making it difficult to disrupt stress fibers. Nevertheless, the fact that Cdc42 silencing results in significant 
stellation prompted us to test whether the GTPase might act downstream of RhoA, and this hypothesis is now 
strengthened by the observed increase in activity of Cdc42 in serum conditions that stimulate RhoA. In that 
perspective however, a difficulty arises as to the fact that each GTPase has widely different effects on the actin 
cytoskeleton, as discussed below. These conflicting notions might be resolved by hypothesizing that RhoA 
activates Cdc42 in parallel with an effector (such as p160Rho-kinase) that induces and maintains actin stress 
fibers in a dominant fashion. Thus, inhibiting RhoA would release pituicytes from cytoskeletal constraints that 
derive from both Cdc42 and the stress fiber-inducing effector, thereby triggering stellation. However, to 
comprehensively account for our results, alternative and perhaps more subtle forms of crosstalk between the two 
GTPases cannot be excluded. 
Relevant to adenosine-induced pituicyte stellation, protein kinase A phosphorylation of a Ser residue has been 
suggested as one mechanism for RhoA inhibition (Lang et al. 1996; Ellerbroek et al. 2003). This indeed might 
represent an intriguing link between metabotropic receptor stimulation and monomeric GTPase inhibition. Given 
our results with phosphorylation-resistant and phosphomimetic mutants, however, this pathway can be ruled out 
regarding adenosine-mediated RhoA inhibition and ensuing stellation. In fact, our results are not surprising 
considering the following points. Ser phosphorylation of RhoA is normally related to its inhibition by a guanine-
nucleotide dissociation inhibitor (GDI; Lang et al. 1996; Ellerbroek et al. 2003). In this case, GTP-bound RhoA 
is not amenable to pull-down analysis (Ellerbroek et al. 2003), which is inconsistent with our previous pull-down 
data (Rosso et al. 2002a). RhoA inhibition by a GTPase-activating protein (GAP) in turn can be measured by 
pull-down (Ellerbroek et al. 2003). Furthermore, as RhoA-G14V, which is protected from GAP-mediated GTP 
hydrolysis, is an efficient stellation inhibitor in our hands, we believe that a GAP-related mechanism is more 
likely to mediate RhoA inhibition by adenosine. Not inconsistent with such a mechanism, Harrington et al. 
(2004) proposed that adenosine downregulates RhoA by decreasing its methylation state via inhibition of S-
adenosylmethionine (SAM)-dependent methyltransferases. In order to rule out such non-receptor-mediated 
effects of adenosine, stellation experiments in the presence of nucleoside transport inhibitors will have to be 
performed. 
Our previous studies suggested that actin stress fibers were responsible for pituicyte spreading and that their 
breakdown was the triggering event for stellation (Rosso et al. 2002a). This view is no longer consistent with the 
observation that Cdc42 activation prevents stellation and maintains spreading while inhibiting stress fibers (Figs. 
6 and 7). We believe that the key observation to account for these effects is that Cdc42 does not simply inhibit 
stress fibers but also appears to reorganize polymerized actin in a cortical fashion, which is consistent with its 
reported induction of actin polymerization at the cell periphery (Gasman et al. 2004). In fact, a similar 
phenomenon can be observed when pituicytes are exposed to VP (inset of Fig. 7), which, as we found, activates 
Cdc42 and reverses stellation (Rosso et al. 2002b). Consistent with these data, pituicyte stellation is completely 
blocked by calyculin-A, an agent that dissolves stress fibers and induces cortical actin redistribution (Kreienbühl 
et al. 1992; Patterson et al. 1999). Incidentally, it would be interesting to investigate, e.g. by pull-down analysis, 
whether calyculin-A directly activates Cdc42. In that respect, it is worth mentioning previous work by others 
(Feoktistov et al. 2000) showing that calyculin-A potentiates cAMP-mediated activation of Cdc42. 
From the above considerations, we could conclude that depolymerized actin, which might represent a default 
state in the absence of monomeric GTPase activity, constitutes a necessary and sufficient factor to induce 
stellation. Indeed, cytochalasin D is a very—if not the most—efficient agent for triggering pituicyte stellation. 
Conversely, our experiments with JPK and calyculin-A indicate that actin polymerization constitutes a sufficient 
condition to prevent stellation. The molecular basis for such a phenomenon remains to be determined. Perhaps 
polymerized actin, whether organized as stress fibers or cortical ring, constitutes a physical or biochemical 
barrier for the microtubule extensions that characterize stellation (Rosso et al. 2002a). Contrary to the clear 
involvement of RhoA and Cdc42, our data suggest that in pituicytes Rac1 may not exert much effect upon actin 
as neither its constitutively active nor its dominant negative forms prevent or induce stellation. Intriguingly, in 
place of its known induction of lamellipodia and membrane ruffles (Hall 1998), Rac1 appears to have a distinct 
dendritogenic effect in pituicytes. 
Published in : Cellular & Molecular Neurobiology (2007) 
Status : Postprint (Author’s version) 
 
From a physiological viewpoint, our results with pituicytes may open a relevant avenue of investigation into the 
mechanisms that regulate the plasticity of other astrocytes of the nervous system in vivo. 
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